{
  "pmcid": "12427675",
  "sha256": "b5a8c24c803ac4fdd08054c7a17844703417fac5244ffb3977ec258c78cfc1af",
  "timestamp_utc": "2025-11-09T23:37:33.527644+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 14.004558573853995,
    "reading_ease": 17.905127334465192,
    "word_count": 248
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Title: Randomised Controlled Trial of VOC Profiling in E. coli Strains"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "This randomised controlled trial was conducted at the Anesthesiology and Intensive Care Unit of the 10th Military Research Hospital and Polyclinic in Bydgoszcz, Poland."
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants included reference strains and 21 clinical isolates of Escherichia coli from VAP patients."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Imipenem addition altered VOC production in the susceptible strain, with levels of six compounds elevated and seven reduced, while resistant profiles remained stable."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study investigates volatile organic compounds (VOCs) as biomarkers for pathogen identification and treatment monitoring."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the identification of VOC emission patterns."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Randomisation and allocation concealment methods were not specified."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding details were not provided."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Participants included reference strains and 21 clinical isolates of Escherichia coli from VAP patients."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "A total of 57 VOCs were identified from the susceptible strain and 41 from the resistant strain."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: Not provided."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 13,
    "max_score": 25
  }
}